Syneos Health Extends Partnership with Medable
13 déc. 2022 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it has extended its strategic...
Syneos Health Reports Third Quarter 2022 Results
04 nov. 2022 06h10 HE
|
Syneos Health, Inc.
Revenue for the third quarter of $1,336.2 million decreased 0.9% on a reported basis and increased 2.2% on a constant currency basis year-over-year.Clinical Solutions net new business awards and...
Syneos Health Appoints William E. Klitgaard Independent Director
14 oct. 2022 16h45 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of William E....
Syneos Health Wins Triangle Business Journal 2022 Leaders in Diversity Award
13 oct. 2022 07h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it has been awarded a Triangle...
Syneos Health Releases Annual Sustainability Report
05 oct. 2022 07h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 2021 Sustainability Report....
Syneos Health Leaders Recognized by HBA
10 mai 2022 09h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 10, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Kasey Boynton, MPH, MBA,...
Syneos Health Promotes Baba Shetty to President, Technology and Data Solutions, and Suma Ramadas to Executive Vice President, Medical Affairs
19 avr. 2022 08h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 19, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the promotions of two senior...
Syneos Health Releases 2022 Dealmakers’ Intentions Survey
11 janv. 2022 09h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 12th annual Dealmakers’...